A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (20)

10016

Dr Dorothy Friedberg, New York

10021

Cornell Univ Med College, New York

19107

Buckley Braffman Stern Med Associates, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

30308

AIDS Research Consortium of Atlanta, Atlanta

33125

Miami Veterans Administration Med Ctr, Miami

60612

Rush Presbyterian - Saint Luke's Med Ctr / Rush Med Coll, Chicago

75219

Oak Lawn Physicians Group, Dallas

77550

Univ TX Galveston Med Branch, Galveston

92103

UCSD Med Ctr / Pediatrics, San Diego

94114

Davies Med Ctr / c/o HIV Institute, San Francisco

94115

Mount Zion Med Ctr, San Francisco

94118

Dr David Busch, San Francisco

94704

East Bay AIDS Ctr, Berkeley

96816

Margo Heath - Chiozzi, Honolulu

98144

Univ of Washington / Pacific Med Ctr, Seattle

900951793

AIDS Clinical Research Ctr / UCLA Med Ctr, Los Angeles

941102859

San Francisco Gen Hosp, San Francisco

02215

Beth Israel Hosp, Boston

Unknown

Saint Paul's Hosp, Vancouver

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002247 - A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy | Biotech Hunter | Biotech Hunter